Functional effects of genetic variants in the 11β-hydroxylase (CYP11B1) gene

被引:15
|
作者
Barr, Marianne
MacKenzie, Scott M.
Wilkinson, Donna M.
Holloway, Christine D.
Friel, Elaine C.
Miller, Stephen
MacDonald, Tom
Fraser, Robert
Connell, John M. C.
Davies, Eleanor
机构
[1] Univ Glasgow, BHF GCRC, Div Cardiovasc & Med Sci, Blood Pressure Grp, Glasgow G12 8TA, Lanark, Scotland
[2] Univ Dundee, Ninewells Hosp & Med Sch, Dept Clin Pharmacol & Therapeut, Dundee DD1 9SY, Scotland
基金
英国医学研究理事会;
关键词
ALDOSTERONE SYNTHASE GENE; CONGENITAL ADRENAL-HYPERPLASIA; SINGLE-NUCLEOTIDE POLYMORPHISMS; ESSENTIAL-HYPERTENSION; ANGIOTENSIN-II; BLOOD-PRESSURE; AMINO-ACID; DEFICIENCY; MUTATIONS; PREVALENCE;
D O I
10.1111/j.1365-2265.2006.02673.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective We previously described an association between the -344C/T 5'-untranslated region (UTR) polymorphism in the CYP11B2 (aldosterone synthase) gene and hypertension with a raised aldosterone to renin ratio (ARR); the same genetic variant is also associated with impaired adrenal 11 beta-hydroxylase efficiency. The -344 polymorphism does not seem to be functional, so is likely to be in linkage with variants in CYP11B1 that determine the associated variation in 11 beta-hydroxylase efficiency. We therefore aimed to determine whether there is an association between CYP11B1 variants and hypertension and/or an altered ARR. Design and measurements We screened 160 subjects divided into four groups, normotensive controls, unselected hypertensive subjects, and hypertensive subjects with either a high (>= 750) or low ARR (<= 200), for variants in the coding region of CYP11B1 by single-stranded conformation polymorphism (SSCP) and direct sequencing. The effects of these variants on enzyme function were assessed by conversion of 11-deoxycortisol to cortisol and 11-deoxycorticosterone (DOC) to corticosterone. Results Eight novel missense mutations were identified in the CYP11B1 gene that alter the encoded amino acids: R43Q, L83S, H125R, P135S, F139L, L158P, L186V and T196A. In each case they were heterozygous changes. However, no mutations were identified that could account for hypertension and/or a raised ARR. The variants L158P and L83S severely impaired enzyme function while R43Q, F139L, P135S and T196A enzymes resulted in product levels that were approximately 30-50% that of wild-type levels. The variant enzymes H125R and L186V resulted in substrate-specific alterations in enzyme function. H125R decreased conversion of 11-deoxycortisol to cortisol and L186V increased 11-deoxycortisol conversion. Neither had an effect on the conversion of DOC to corticosterone. Conclusion No variants were identified in the coding region of CYP11B1 that could account for hypertension and/or a raised ARR. However, this in vitro study identifies the importance of these affected residues to enzyme function and will inform subsequent studies of structure-function relationships.
引用
收藏
页码:816 / 825
页数:10
相关论文
共 50 条
  • [1] 11β-Hydroxylase (CYP11B1) gene variants and new-onset depression in later life
    Ancelin, Marie-Laure
    Norton, Joanna
    Ritchie, Karen
    Chaudieu, Isabelle
    Ryan, Joanne
    JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 2021, 46 (01): : E147 - E153
  • [2] Detection of Small CYP11B1 Deletions and One Founder Chimeric CYP11B2/CYP11B1 Gene in 11β-Hydroxylase Deficiency
    Xie, Hua
    Yin, Hui
    Ye, Xue
    Liu, Ying
    Liu, Na
    Zhang, Yu
    Chen, Xiaoli
    Chen, Xiaobo
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [3] A novel mutation in the CYP11B1 gene in a patient with 11β-hydroxylase deficiency
    Motaghedi, R
    Slowinska, B
    Cerami, B
    Cabrera, M
    New, MI
    Wilson, RC
    AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (05) : 79A - 79A
  • [4] Characterization of polymorphisms at the 11β-hydroxylase (CYP11B1) locus
    Skinner, CA
    Yousaf, N
    Honour, JW
    Rumsby, G
    ANNALS OF HUMAN GENETICS, 1998, 62 : 181 - 183
  • [5] Association between aldosterone production and variation in the 11β-hydroxylase (CYP11B1) gene
    Imrie, Helen
    Freel, Marie
    Mayosi, Bongani M.
    Davies, Eleanor
    Fraser, Robert
    Ingram, Mary
    Cordell, Heather J.
    Farrall, Martin
    Avery, Peter J.
    Watkins, Hugh
    Keavney, Bernard
    Connell, John M. C.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (12): : 5051 - 5056
  • [6] Identification and Functional Characterization of a Large Deletion of the CYP11B1 Gene Causing an 11β-Hydroxylase Deficiency in a Chinese Pedigree
    Xu, Chao
    Qiao, Jie
    Liu, Wei
    Jiang, Xiuyun
    Yan, Fang
    Wu, Jiajun
    Han, Bing
    Zhang, Haiqing
    Guan, Qingbo
    Gao, Ling
    Zhao, Jiajun
    HORMONE RESEARCH IN PAEDIATRICS, 2012, 78 (04): : 212 - 217
  • [7] Novel Mutations in CYP11B1 Gene Leading to 11β-Hydroxylase Deficiency in Brazilian Patients
    Soardi, Fernanda C.
    Penachioni, Junia Y.
    Justo, Giselle Z.
    Bachega, Tania A. S. S.
    Inacio, Marlene
    Mendonca, Berenice B.
    de Castro, Margaret
    de Mello, Maricilda P.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (09): : 3481 - 3485
  • [8] Clinical Presentation and Genetic Analysis of Neonatal 11(3-Hydroxylase (3-Hydroxylase Deficiency Induced by a Chimeric CYP11B2/ CYP11B1 Gene
    Cai, Wenjuan
    Yu, Dan
    Gao, Jian
    Deng, Qian
    Lin, Huihui
    Chen, Yuqing
    JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY, 2024, 16 (03) : 372 - 378
  • [9] Molecular analysis of 12 Chinese patients with 11β-hydroxylase deficiency and in vitro functional study of 20 CYP11B1 missense variants
    Sun, Bang
    Lu, Lin
    Xie, Shaowei
    Zhang, Wei
    Zhang, Xiaoxia
    Tong, Anli
    Chen, Shi
    Wu, Xueyan
    Mao, Jiangfeng
    Wang, Xi
    Qiu, Ling
    Nie, Min
    FASEB JOURNAL, 2023, 37 (04):
  • [10] Detection and activity of 11 beta hydroxylase (CYP11B1) in the bovine ovary
    Amweg, A. N.
    Rodriguez, F. M.
    Huber, E.
    Marelli, B. E.
    Gareis, N. C.
    Belotti, E. M.
    Rey, F.
    Salvetti, N. R.
    Ortega, H. H.
    REPRODUCTION, 2017, 153 (04) : 433 - 441